TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 22,339 | 25,130 | 21,990 |
Financial expenses | 48 | 16 | 21 |
Earnings before taxes | 159 | 4,102 | 2,388 |
EBITDA | 595 | 4,441 | 2,689 |
Total assets | 24,974 | 22,656 | 10,179 |
Current assets | 13,409 | 11,287 | 8,984 |
Current liabilities | 4,303 | 3,274 | 3,100 |
Equity capital | 16,215 | 16,112 | 4,371 |
- share capital | 200 | 200 | 200 |
Employees (average) | 14 | 14 | 14 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 64.9% | 71.1% | 42.9% |
Turnover per employee | 1,596 | 1,795 | 1,571 |
Profit as a percentage of turnover | 0.7% | 16.3% | 10.9% |
Return on assets (ROA) | 0.8% | 18.2% | 23.7% |
Current ratio | 311.6% | 344.7% | 289.8% |
Return on equity (ROE) | 1.0% | 25.5% | 54.6% |
Change turnover | -2,791 | 3,140 | -1,953 |
Change turnover % | -11% | 14% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.